Your browser doesn't support javascript.
loading
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.
Orozco, Johnnie J; Kenoyer, Aimee; Balkin, Ethan R; Gooley, Ted A; Hamlin, Donald K; Wilbur, D Scott; Hylarides, Mark D; Frost, Sofia H L; Mawad, Raya; O'Donnell, Paul; Sandmaier, Brenda M; Fuchs, Ephraim J; Luznik, Leo; Green, Damian J; Gopal, Ajay K; Press, Oliver W; Pagel, John M.
Afiliação
  • Orozco JJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Hematology Division, Department of Medicine, University of Washington School of Medicine, Seattle, WA;
  • Kenoyer A; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Balkin ER; Radiation Oncology, University of Washington, Seattle, WA;
  • Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Hamlin DK; Radiation Oncology, University of Washington, Seattle, WA;
  • Wilbur DS; Radiation Oncology, University of Washington, Seattle, WA;
  • Hylarides MD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Frost SH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Mawad R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
  • O'Donnell P; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
  • Fuchs EJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Luznik L; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Green DJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
  • Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
  • Press OW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
  • Pagel JM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
Blood ; 127(3): 352-9, 2016 Jan 21.
Article em En | MEDLINE | ID: mdl-26576864
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Haplótipos / Radioimunoterapia / Antígenos Comuns de Leucócito / Imunoconjugados / Condicionamento Pré-Transplante / Sobrevivência de Enxerto Limite: Animals / Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Haplótipos / Radioimunoterapia / Antígenos Comuns de Leucócito / Imunoconjugados / Condicionamento Pré-Transplante / Sobrevivência de Enxerto Limite: Animals / Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article